Reuters logo
3 months ago
BRIEF-MolMed and Megapharm enter into a license and distribution agreement for Zalmoxis in Israel
April 28, 2017 / 3:59 PM / 3 months ago

BRIEF-MolMed and Megapharm enter into a license and distribution agreement for Zalmoxis in Israel

1 Min Read

April 28 (Reuters) - MolMed SpA:

* Molmed and Megapharm sign licensing and distribution contract for Zalmoxis in Israel

* Zalmoxis will be distributed and marketed by Megapharm, once approved by the Israeli Ministry of Health (MOH) and included in the Israeli national health basket of drugs by the MOH

* Zalmoxis is a cell-based therapy enabling bone marrow transplants from partially compatible donors currently in Phase III in high-risk acute leukemia Source text: www.1info.it Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below